ストックスクリーナーアプリを入手
6.40
2.14%
-0.14
前日終値:
$6.54
開ける：
$6.45
24時間の取引高:
2,611
Relative Volume:
0.08
時価総額：
$88.66M
収益：
$49.98M
当期純損益:
$-9.64M
株価収益率:
-9.0141
EPS:
-0.71
ネットキャッシュフロー:
$-4.86M
1週間 パフォーマンス:
-0.31%
1か月 パフォーマンス:
-6.30%
6か月 パフォーマンス:
-12.81%
1年 パフォーマンス:
+40.97%
1日の値動き範囲:
$6.35
$6.47
1週間の範囲:
$6.3201
$6.8907
52週間の値動き範囲:
$3.75
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
名前
Champions Oncology Inc
セクター
電話
410-369-0365
住所
855 N. WOLFE STREET, BALTIMORE, NJ
CSBR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.43 | 90.18M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.04 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.31 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.94 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-12 | アップグレード | Craig Hallum | Hold → Buy |
| 2019-11-18 | 開始されました | The Benchmark Company | Speculative Buy |
Champions Oncology Inc (CSBR) 最新ニュース
What moving averages say about Champions Oncology Inc.July 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Will Champions Oncology Inc. bounce back from current support2025 Year in Review & Daily Stock Trend Reports - newser.com
Will Champions Oncology Inc. stock see insider buyingMarket Movers & Weekly High Potential Stock Alerts - newser.com
Is Champions Oncology Inc. showing signs of accumulationInflation Watch & Fast Entry Momentum Alerts - newser.com
Sentiment analysis tools applied to Champions Oncology Inc.Market Risk Summary & Technical Buy Zone Confirmations - newser.com
How Champions Oncology Inc. (2I3) stock reacts to stronger dollar2025 Momentum Check & Free Community Consensus Stock Picks - newser.com
3 Dividend Champion Stocks I'm Watching in 2025 - sharewise.com
Will Champions Oncology Inc. (2I3) stock benefit from sector leadershipJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
Will Champions Oncology Inc. (2I3) stock keep raising dividendsJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
How to interpret RSI for Champions Oncology Inc. stockWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Relative strength of Champions Oncology Inc. in sector analysisWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
Volatility clustering patterns for Champions Oncology Inc.Profit Target & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Champions Oncology Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Why Champions Oncology Inc. (2I3) stock could rally stronglyEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Is Champions Oncology Inc. stock ready for breakout2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Can Champions Oncology Inc. stock maintain operating marginsForecast Cut & AI Forecast Swing Trade Picks - newser.com
Visual analytics tools that track Champions Oncology Inc. performanceDividend Hike & Precise Entry and Exit Recommendations - newser.com
Best data tools to analyze Champions Oncology Inc. stockWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Institutional scanner results for Champions Oncology Inc.Trade Volume Summary & Verified Chart Pattern Signals - newser.com
Is Champions Oncology Inc. a candidate for recovery playPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Why Champions Oncology Inc. stock appeals to analysts2025 Pullback Review & AI Driven Stock Reports - newser.com
What drives Champions Oncology Inc 2I3 stock priceSector ETF Performance & Double Or Triple Capital - earlytimes.in
Champions Oncology Inc Stock Analysis and ForecastStock Price Divergence & Free Phenomenal Investment Performance - earlytimes.in
Champions Oncology Inc 2I3 Stock Analysis and ForecastGlobal Trade Effects & Outstanding Investment Returns - earlytimes.in
13% of Sales Support Breast Cancer Research: Athleta x Kristin Juszczyk Launch Limited Edition Sports Bra - Stock Titan
Champions Oncology Inc (CSBR) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
大文字化:
|
ボリューム (24 時間):